A detailed history of Tradewinds Capital Management, LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 200 shares of BLRX stock, worth $56. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$56
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$1.23 - $2.45 $246 - $490
200 New
200 $0

Others Institutions Holding BLRX

About BioLineRx Ltd.


  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $17.2M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.